Ursodiol disulfate

Drug Profile

Ursodiol disulfate

Alternative Names: Disulfate conjugate of ursodeoxycholate (SUDCA); SUDCA; Ursodeoxycholic acid-disulfate

Latest Information Update: 11 Aug 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cincinnati Childrens Hospital Medical Center
  • Class Antineoplastics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Colorectal cancer; Liver transplant rejection

Most Recent Events

  • 25 Feb 2008 Axcan Pharma has been acquired by Texas Pacific Group
  • 23 Feb 2007 Discontinued - Preclinical for Liver transplant rejection in Canada (IV)
  • 30 Sep 2006 Axcan completes a second phase I trial in Colorectal cancer in Canada
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top